Shares of Alembic Pharmaceuticals Ltd. rose 1.5% to Rs 773.5 apiece after the company received the U.S. FDA nod for its ANDA for Fesoterodine Fumarate Extended-Release tablets, 4 mg and 8 mg. It is indicated for treatment of overactive bladder in adults. The estimated market size of $225 million for twelve months ending September 2021, according to IQVIA.
Alembic Pharma
Alembic Pharma At Over 14-month High After Receiving FDA Approval
Gold Silver Reports (GSR) – Shares of the drugmaker rose as much as 4.2 percent to trade over a 14-month high at Rs 614.25.
The pharmaceutical company received a green signal from the U.S. drug regulator for its Bimatoprost Ophthalmic solution, according to its statement on the exchanges. The frug is used to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness, the statement added.
Stocks To Watch: Alembic Pharma, Century Textiles, Indiabulls Real Estate, Alembic Pharma
Gold Silver Reports (GSR) – Stocks To Watch: Alembic Pharma, Century Textiles, Indiabulls Real Estate, Alembic Pharma – Indian equity benchmarks fell for the fourth straight day as Indian companies reported weaker-than-estimated earnings for the January-March quarter. The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index’s performance in India, traded unchanged at 10,615 as of 7:20 a.m.
Alembic Pharma Gains On Drug Approval
Alembic Pharma Gains On Drug Approval Shares of the Vadodara-based pharmaceutical firm rose as much as 5.4 percent to Rs 570. Alembic Pharmaceuticals has received approval from the U.S. drug regulator for Acyclovir, which is used in the treatment of genital herpes, it said in a notification to the stock …